Connor, Clark & Lunn Investment Management Ltd. - LUMOS PHARMA INC ownership

LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 41 filers reported holding LUMOS PHARMA INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of LUMOS PHARMA INC
ValueSharesWeighting
Q3 2022$295,000
+14.8%
33,3670.0%0.00%0.0%
Q2 2022$257,000
-18.4%
33,3670.0%0.00%0.0%
Q1 2022$315,000
+35.8%
33,367
-0.2%
0.00%
+100.0%
Q4 2021$232,000
-27.0%
33,4270.0%0.00%
-50.0%
Q3 2021$318,000
+0.3%
33,427
+4.7%
0.00%0.0%
Q2 2021$317,000
-18.7%
31,938
-4.1%
0.00%0.0%
Q1 2021$390,000
-65.1%
33,293
+6.5%
0.00%
-71.4%
Q4 2020$1,116,000
+152.5%
31,251
-2.3%
0.01%
+133.3%
Q3 2020$442,000
-26.6%
31,978
-12.5%
0.00%
-25.0%
Q2 2020$602,000
+91.1%
36,531
-1.3%
0.00%
+33.3%
Q1 2020$315,00037,0300.00%
Other shareholders
LUMOS PHARMA INC shareholders Q4 2022
NameSharesValueWeighting ↓
Minerva Advisors LLC 34,015$321,0000.21%
Lion Point Capital, LP 51,205$481,0000.11%
Wealth Advisors of Iowa, LLC 11,699$110,0000.06%
NEA Management Company, LLC 167,608$1,575,0000.04%
Paladin Advisory Group, LLC 4,382$40,0000.03%
Marquette Asset Management, LLC 13,315$125,0000.03%
Blackstone Inc. 468,145$4,401,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 47,643$450,0000.01%
Jefferies Group LLC 120,651$1,134,1190.01%
Renaissance Technologies 271,712$2,554,0000.00%
View complete list of LUMOS PHARMA INC shareholders